Patents by Inventor Ingo Kober

Ingo Kober has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Service variants for enterprise services
    Patent number: 8839189
    Abstract: Implementations of the present disclosure include executing a business application on a server device, the business application executing a service based on a base plurality of inputs, accessing a first service variant based on the service, generating a first plurality of input fields based on the first service variant, the first plurality of input fields corresponding to a first plurality of inputs, the first plurality of inputs being a sub-set of the base plurality of inputs, and executing the service based on the first plurality of inputs that is input using the first plurality of input fields.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: September 16, 2014
    Assignee: SAP AG
    Inventors: Knut Thies, Anne Jacobi, Ingo Kober, Michael Schmitt, Bertram Vielsack, Ruediger Karl, Sven Kruppel-Berndt
  • Piperidine and piperazine derivatives
    Patent number: 8791111
    Abstract: Compounds of the formula (I), in which R1, R2, R3, D, G, Q and W have the meanings indicated in Claim (1), can and be employed for the treatment of tumors.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: July 29, 2014
    Assignee: Merck Patent GmbH
    Inventors: Kai Schiemann, Melanie Schultz, Andree Blaukat, Ingo Kober
  • Piperidine and piperazine derivatives
    Patent number: 8754097
    Abstract: Compounds of the formula (I), in which R1, R2, R3, D, G, Q and W have the meanings indicated in claim (1), can and be employed for the treatment of tumors.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: June 17, 2014
    Assignee: Merck Patent GmbH
    Inventors: Kai Schiemann, Melanie Schultz, Andree Blaukat, Ingo Kober
  • Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
    Patent number: 8575161
    Abstract: The present invention relates to compounds of formula (I) wherein the substituents are as defined in the claims, including pharmaceutical compositions thereof and for their use in the treatment and/or prevention and/or amelioration of one or more symptoms of disease or disorders related to the activity of FXR. The invention is also directed to intermediates and to a method of preparation of compounds of formula (I).
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: November 5, 2013
    Assignee: Merck Patent GmbH
    Inventors: Didier Roche, Gisèle Mautino, Ingo Kober, Francis Contard, Serge Christmann-Franck, Saumitra Sengupta, Ramesh Sistla, Gummadi Venkateshwar Rao
  • Thiazole derivatives
    Patent number: 8557824
    Abstract: Compounds of the formula (I), in which R1, R2, R3, R4, K, G, E and W
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: October 15, 2013
    Assignee: Merck Patent GmbH
    Inventors: Kai Schiemann, Melanie Schultz, Andree Blaukat, Ingo Kober, Wolfgang Staehle
  • 2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer
    Patent number: 8530650
    Abstract: The present invention relates to pyridopyrimidine derivatives according to formula (I) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: September 10, 2013
    Assignee: MERCK PATENT GmbH
    Inventors: Kai Schiemann, Melanie Schultz, Wolfgang Staehle, Ingo Kober, Dirk Wienke, Mireille Krier
  • PIPERIDINE AND PIPERAZINE DERIVATIVES
    Publication number: 20120316162
    Abstract: Compounds of the formula (I), in which R1, R2, R3, D, G, Q and W have the meanings indicated in claim (1), can and be employed for the treatment of tumours.
    Type: Application
    Filed: August 22, 2012
    Publication date: December 13, 2012
    Applicant: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Kai SCHIEMANN, Melanie SCHULTZ, Andree BLAUKAT, Ingo KOBER
  • 2, 5-DIAMINO-SUBSTITUTED PYRIDO [4, 3-D] PYRIMIDINES AS AUTOTAXIN INHIBITORS AGAINST CANCER
    Publication number: 20110237583
    Abstract: The present invention relates to pyridopyrimidine derivatives according to formula (I) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
    Type: Application
    Filed: November 3, 2009
    Publication date: September 29, 2011
    Inventors: Kai Schiemann, Melanie Schultz, Wolfgang Staehle, Ingo Kober, Dirk Wienke, Mireille Krier
  • BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN
    Publication number: 20110230471
    Abstract: Compounds of the formula (I), in which R1, R2, R3, R4, R5, D, Z, X, Y, m and p have the meanings indicated in Claim 1, can and be employed for the treatment of tumours.
    Type: Application
    Filed: November 5, 2009
    Publication date: September 22, 2011
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Wolfgang Staehle, Ingo Kober, Kai Schiemann, Melanie Schultz, Dirk Wienke
  • BENZOFURANE, BENZOTHIOPHENE, BENZOTHIAZOL DERIVATIVES AS FXR MODULATORS
    Publication number: 20110105475
    Abstract: The present invention relates to compounds of formula (I) wherein the substituents are as defined in the claims, including pharmaceutical compositions thereof and for their use in the treatment and/or prevention and/or amelioration of one or more symptoms of disease or disorders related to the activity of FXR. The invention is also directed to intermediates and to a method of preparation of compounds of formula (I).
    Type: Application
    Filed: March 30, 2009
    Publication date: May 5, 2011
    Applicant: MERXCK PATENT GESELLSCHAFT
    Inventors: Didier Roche, Giséle Mautino, Ingo Kober, Francis Contard, Serge Christmann-Franck, Saumitra Sengupta, Ramesh Sistla, Gummadi Venkateshwar Rao
  • SERVICE VARIANTS FOR ENTERPRISE SERVICES
    Publication number: 20110078654
    Abstract: Implementations of the present disclosure include executing a business application on a server device, the business application executing a service based on a base plurality of inputs, accessing a first service variant based on the service, generating a first plurality of input fields based on the first service variant, the first plurality of input fields corresponding to a first plurality of inputs, the first plurality of inputs being a sub-set of the base plurality of inputs, and executing the service based on the first plurality of inputs that is input using the first plurality of input fields.
    Type: Application
    Filed: September 30, 2009
    Publication date: March 31, 2011
    Applicant: SAP AG
    Inventors: Knut Thies, Anne Jacobi, Ingo Kober, Michael Schmitt, Bertram Vielsack, Ruediger Karl, Sven Kruppel-Berndt
  • IMIDAZOLE DERIVATIVES
    Publication number: 20100249132
    Abstract: Compounds of the formula (I), in which R1, D, E, L, Q, X and q have the meanings indicated in Claim 1, can and be employed for the treatment of tumours.
    Type: Application
    Filed: September 9, 2008
    Publication date: September 30, 2010
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Melanie Schultz, Kai Schiemann, Gerard Botton, Andree Blaukat, Ingo Kober
  • THIAZOLE DERIVATIVES
    Publication number: 20100240676
    Abstract: Compounds of the formula (I), in which R1, R2, R3, R4, K, G, E and W
    Type: Application
    Filed: September 19, 2008
    Publication date: September 23, 2010
    Applicant: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Kai Schiemann, Melanie Schultz, Andree Blaukat, Ingo Kober, Wolfgang Staehle
  • PIPERIDINE AND PIPERAZINE DERIVATIVES
    Publication number: 20100222341
    Abstract: Compounds of the formula (I), in which R1, R2, R3, D, G, Q and W have the meanings indicated in claim (1), can and be employed for the treatment of tumours.
    Type: Application
    Filed: September 19, 2008
    Publication date: September 2, 2010
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HARTUNG
    Inventors: Kai Schiemann, Melanie Schultz, Andree Blaukat, Ingo Kober
  • Nr1h4 nuclear receptor binding compounds
    Publication number: 20070010562
    Abstract: The present invention relates to compounds according to the general formula (1) which bind to the NR1H4 receptor and act as agonists, antagonists or mixed agonists/antagonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and the production of medicaments using said compounds.
    Type: Application
    Filed: August 13, 2002
    Publication date: January 11, 2007
    Inventors: Ulrike Bauer, Zach Cheruvallath, Ulrich Deuschle, Elena Dneprovskaia, Tim Gahman, Kristina Giegrich, Ronnie Hanecak, Normand Hebert, John Kiely, Ingo Kober, Manfred Kogl, Harald Kranz, Claus Kremoser, Matthew Lee, Kerstin Otte, Carlton Sage, Manish Sud
  • FXR NR1H4 nuclear receptor binding compounds
    Patent number: 7098336
    Abstract: The invention provides compounds according to the general formula (1) which bind to the NR1H4 receptor and act as agonists, antagonists or mixed agonists/antagonists of the NR1H4 receptor. The invention further provides methods of treating diseases and/or conditions through binding of the nuclear receptor by the compounds and the production of medicaments using the compounds.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: August 29, 2006
    Assignee: Phenex Pharmaceuticals AG
    Inventors: Ulrike Bauer, Zach Cheruvallath, Ulrich Deuschle, Elena Dneprovskaia, Tim Gahman, Kristina Giegrich, Ronnie Hanecak, Normand Hébert, John Kiely, Ingo Kober, Manfred Kögl, Harald Kranz, Claus Kremoser, Matthew Lee, Kerstin Otte, Carlton Sage, Manish Sud
  • Nr3b1 nuclear receptor binding 3-substituted pyrazoles
    Publication number: 20060148876
    Abstract: The present invention relates to compounds according to the general formula (I) which bind to the NR3B1 receptor and act as antagonists or agonists of the NR3B1 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and the production of medicaments using said compounds.
    Type: Application
    Filed: July 2, 2003
    Publication date: July 6, 2006
    Inventors: Ulrich Deuschle, Stefanie Heck, Ingo Kober, Ulrike Bauer, Imola Balogh
  • NR1H4 nuclear receptor binding compounds
    Patent number: 7034046
    Abstract: The present invention relates to compounds according to the general formula (I) which bind to the nuclear receptor, NR1H4, and act as agonists and antagonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of the nuclear receptor by the compounds.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: April 25, 2006
    Assignee: Phenex Pharmaceuticals AG
    Inventors: Ulrike Bauer, Zach Cheruvallath, Ulrich Deuschle, Elena Dneprovskaia, Tim Gahman, Kristina Giegrich, Ronnie Hanecak, Normand Hébert, John Kiely, Ingo Kober, Manfred Kögl, Harald Kranz, Claus Kremoser, Matthew Lee, Kerstin Otte, Carlton Sage, Manish Sud
  • NR1H4 nuclear receptor binding compounds
    Patent number: 6974830
    Abstract: The present invention relates to compounds according to the general formula (I) which bind to the NR1H4 receptor and act as agonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of the nuclear receptor by the compounds and the production of medicaments using the compounds.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: December 13, 2005
    Assignee: Phenix Pharmaceuticals AG
    Inventors: Ulrike Bauer, Zach Cheruvallath, Ulrich Deuschle, Elena Dneprovskaia, Tim Gahman, Kristina Giegrich, Ronnie Hanecak, Normand Hébert, John Kiely, Ingo Kober, Manfred Kögl, Harald Kranz, Claus Kremoser, Matthew Lee, Kerstin Otte, Carlton Sage, Manish Sud
  • Novel 2-amino-4-quinazolinones and 2-amino-4-oxoquinazolones as LXR nuclear receptor binding compounds with partial agonistic properties
    Publication number: 20050261319
    Abstract: The present invention relates to compounds according to the general formulas (I) and/or (Ia), which bind to the LXR receptors and act as agonists and antagonists of the LXR receptors. The invention further relates to the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and the production of medicaments using said compounds.
    Type: Application
    Filed: March 9, 2005
    Publication date: November 24, 2005
    Inventors: Ulrich Deuschle, Ralph Loebbert, Beatrix Blume, Manfred Koegl, Claus Kremoser, Ingo Kober, Ulrike Bauer, Kristina Hermann, Michael Albers